Although CRAF is not crucial for ERK activation, its significance in tumorigenesis and cancer progression largely arises from interactions and cross-talk with other signaling pathways, culminating in non-oncogene addiction in RAS-driven lung cancers and PDAC [74, 85]. This evidence concerns the gene MAPK1 and cancer.